Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -16.95% vs -0.90% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 18.18% vs 11.39% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -6.23% vs -15.00% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 11.99% vs 19.28% in Mar 2025
Compare Balance Sheet Results of Goldline Pharmac
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.71
12.31
-3.60
-29.24%
Share Warrants & Outstandings
Total Reserve
5.54
33.10
-27.56
-83.26%
Shareholder's Funds
14.25
45.42
-31.17
-68.63%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.21
2.38
0.83
34.87%
Secured Loans
0.66
2.38
-1.72
-72.27%
Unsecured Loans
2.55
0.00
2.55
0.00%
Deferred Tax Assets / Liabilities
-0.08
-4.37
4.29
98.17%
Other Long Term Liabilities
1.04
0.00
1.04
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.12
-0.12
-100.00%
Total Non-Current Liabilities
2.43
-1.87
4.30
229.95%
Current Liabilities
Trade Payables
1.85
5.59
-3.74
-66.91%
Other Current Liabilities
2.56
1.74
0.82
47.13%
Short Term Borrowings
7.70
5.02
2.68
53.39%
Short Term Provisions
0.00
0.01
-0.01
-100.00%
Total Current Liabilities
12.11
12.37
-0.26
-2.10%
Total Liabilities
28.79
55.92
-27.13
-48.52%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.76
27.18
-23.42
-86.17%
Less: Accumulated Depreciation
1.06
8.48
-7.42
-87.50%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.71
18.70
-15.99
-85.51%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
10.14
-10.14
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.03
0.05
-0.02
-40.00%
Long Term Loans & Advances
0.02
2.12
-2.10
-99.06%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
2.75
31.01
-28.26
-91.13%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.21
8.22
-2.01
-24.45%
Sundry Debtors
16.13
13.54
2.59
19.13%
Cash and Bank
0.59
0.73
-0.14
-19.18%
Other Current Assets
1.13
0.41
0.72
175.61%
Short Term Loans and Advances
1.98
2.00
-0.02
-1.00%
Total Current Assets
26.05
24.91
1.14
4.58%
Net Current Assets (Including Current Investments)
13.93
12.54
1.39
11.08%
Total Current Assets Excluding Current Investments
26.05
24.91
1.14
4.58%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
28.79
55.92
-27.13
-48.52%
Contingent Liabilities
3.37
0.00
3.37
0.00%
Total Debt
7.41
7.40
0.01
0.14%
Book Value per share (adjusted)
18.03
7.38
10.65
144.31%
Annual - Borrowings
Borrowings 9.16 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -16.95% vs -0.90% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.04 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 18.18% vs 11.39% in Mar 2025
Annual - Fixed Assets
Fixed Assets 2.71 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -6.23% vs -15.00% in Mar 2025
Annual - Investments
Investments 0.03 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 26.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.99% vs 19.28% in Mar 2025






